Wall Street Analysts Think Corbus Pharmaceuticals (CRBP) Could Surge 43.82%: Read This Before Placing a Bet

Group 1 - Corbus Pharmaceuticals (CRBP) closed at $59.70, with a 2.8% gain over the past four weeks, and a mean price target of $85.86 suggests a 43.8% upside potential [1] - The average price targets from analysts range from a low of $76 to a high of $105, with a standard deviation of $9.30, indicating variability in estimates [2] - Analysts have shown increasing optimism regarding CRBP's earnings prospects, with a strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [9][10] Group 2 - The Zacks Consensus Estimate for CRBP has increased by 25.3% due to three estimates moving higher in the last 30 days [10] - CRBP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does provide a directional guide for price movement [11]